Search for Clinical Trials

This study is a first in human Phase 1 study that involves patients with a type of cancer called HER2 (Human Epidermal Growth Factor Receptor 2)…
  • Cancer - Breast
  • Cancer - Head/Neck
  • Cancer - Gastric/Stomach
  • Cancer - Esophagus
  • Cancer - Colon/Rectal
  • Cancer - Bladder
  • Cancer - All
  • Cancer - Pancreas
  • Cancer - Lung
A study to determine if the combination of avelumab with several different drugs is safe and effective for treating patients with metastatic triple-…
  • Cancer - Breast
  • Cancer - Metastatic
This study is to find out if patients with HER2-positive breast cancer who have no cancer remaining at surgery after 12 weeks of chemotherapy and 2…
  • Cancer - Breast
This study is being done to find out if tucatinib plus T-DM1 works better to treat breast cancer than T-DM1 alone. Tucatinib is a type of drug…
  • Cancer - Breast
  • Cancer - Metastatic
The purpose of this study is to compare existing treatment with any effects of receiving 1 year of treatment with pembrolizumab after surgery.
  • Cancer - Breast
A study to determine if the addition of atezolizumab to chemotherapy improves response in the breast and lymph nodes in patients with triple-negative…
  • Cancer - Breast
The purpose of this study is to find out if adding simvastatin to dual anti-HER2 treatment can slow down the growth or reduce the size of your…
  • Cancer - Breast
  • Cancer - Metastatic
This study is to see how ruxolitinib changes the breast cells when given to patients with premalignant breast conditions in order to know if it might…
  • Cancer - Breast
The Phase 1 part of the study is being done to test the safety and effectiveness of ZN-c5 (investigational oral medication) at different dose levels…
  • Cancer - Breast
  • Cancer - Metastatic
Back to topback-to-top